ALVO
Price
$8.32
Change
+$0.20 (+2.46%)
Updated
Sep 26, 12:57 PM (EDT)
Capitalization
2.53B
47 days until earnings call
EBS
Price
$8.80
Change
+$0.06 (+0.69%)
Updated
Sep 26, 01:04 PM (EDT)
Capitalization
466.29M
40 days until earnings call
Interact to see
Advertisement

ALVO vs EBS

Header iconALVO vs EBS Comparison
Open Charts ALVO vs EBSBanner chart's image
Alvotech
Price$8.32
Change+$0.20 (+2.46%)
Volume$100
Capitalization2.53B
Emergent Biosolutions
Price$8.80
Change+$0.06 (+0.69%)
Volume$200
Capitalization466.29M
ALVO vs EBS Comparison Chart in %
Loading...
ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALVO vs. EBS commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALVO is a StrongBuy and EBS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (ALVO: $8.12 vs. EBS: $8.74)
Brand notoriety: ALVO and EBS are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ALVO: 74% vs. EBS: 115%
Market capitalization -- ALVO: $2.53B vs. EBS: $466.29M
ALVO [@Pharmaceuticals: Generic] is valued at $2.53B. EBS’s [@Pharmaceuticals: Generic] market capitalization is $466.29M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALVO’s FA Score shows that 1 FA rating(s) are green whileEBS’s FA Score has 1 green FA rating(s).

  • ALVO’s FA Score: 1 green, 4 red.
  • EBS’s FA Score: 1 green, 4 red.
According to our system of comparison, EBS is a better buy in the long-term than ALVO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALVO’s TA Score shows that 4 TA indicator(s) are bullish while EBS’s TA Score has 6 bullish TA indicator(s).

  • ALVO’s TA Score: 4 bullish, 4 bearish.
  • EBS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, EBS is a better buy in the short-term than ALVO.

Price Growth

ALVO (@Pharmaceuticals: Generic) experienced а +3.84% price change this week, while EBS (@Pharmaceuticals: Generic) price change was +10.08% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.88%. For the same industry, the average monthly price growth was +23.85%, and the average quarterly price growth was +67.10%.

Reported Earning Dates

ALVO is expected to report earnings on Nov 12, 2025.

EBS is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.88% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALVO($2.53B) has a higher market cap than EBS($466M). ALVO has higher P/E ratio than EBS: ALVO (35.30) vs EBS (3.34). EBS YTD gains are higher at: -8.577 vs. ALVO (-38.624). EBS has higher annual earnings (EBITDA): 344M vs. ALVO (207M). EBS has more cash in the bank: 267M vs. ALVO (151M). EBS has less debt than ALVO: EBS (668M) vs ALVO (1.27B). EBS has higher revenues than ALVO: EBS (812M) vs ALVO (560M).
ALVOEBSALVO / EBS
Capitalization2.53B466M543%
EBITDA207M344M60%
Gain YTD-38.624-8.577450%
P/E Ratio35.303.341,058%
Revenue560M812M69%
Total Cash151M267M57%
Total Debt1.27B668M190%
FUNDAMENTALS RATINGS
EBS: Fundamental Ratings
EBS
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
32
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
43
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALVOEBS
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
49%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
48%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bullish Trend 1 day ago
40%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
64%
Bullish Trend 1 day ago
77%
Declines
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 10 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
49%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VLEQX11.14N/A
N/A
Villere Equity
FISPX8.85N/A
N/A
Federated Hermes Max-Cap Index IS
TRPWX23.52N/A
N/A
Nuveen Quant Mid Cap Growth R6
DFSTX51.63N/A
N/A
DFA US Small Cap I
MSGFX32.18N/A
N/A
Morgan Stanley Inst Global Franchise C

ALVO and

Correlation & Price change

A.I.dvisor tells us that ALVO and EBS have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
-5.36%
EBS - ALVO
26%
Poorly correlated
+5.43%
CRON - ALVO
22%
Poorly correlated
-2.58%
ACB - ALVO
22%
Poorly correlated
-4.44%
PBH - ALVO
21%
Poorly correlated
-0.84%
CURLF - ALVO
21%
Poorly correlated
-6.87%
More

EBS and

Correlation & Price change

A.I.dvisor indicates that over the last year, EBS has been loosely correlated with SIGA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if EBS jumps, then SIGA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EBS
1D Price
Change %
EBS100%
+5.43%
SIGA - EBS
42%
Loosely correlated
-1.46%
VTRS - EBS
41%
Loosely correlated
-2.27%
ELAN - EBS
35%
Loosely correlated
+0.91%
PAHC - EBS
30%
Poorly correlated
-0.55%
ZOMDF - EBS
29%
Poorly correlated
-1.05%
More